<SEC-DOCUMENT>0001493152-26-035261.txt : 20260729
<SEC-HEADER>0001493152-26-035261.hdr.sgml : 20260729
<ACCEPTANCE-DATETIME>20260729172547
ACCESSION NUMBER:		0001493152-26-035261
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260723
FILED AS OF DATE:		20260729
DATE AS OF CHANGE:		20260729

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Levy Adam R.
		CENTRAL INDEX KEY:			0001794090
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41173
		FILM NUMBER:		261219312

	MAIL ADDRESS:	
		STREET 1:		2 AVENUE OF TWO RIVER SOUTH
		CITY:			RUMSON
		STATE:			NJ
		ZIP:			07760

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NEXGEL, INC.
		CENTRAL INDEX KEY:			0001468929
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				264042544
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		2150 CABOT BLVD WEST,
		STREET 2:		SUITE B
		CITY:			LANGHORNE
		STATE:			PA
		ZIP:			19047
		BUSINESS PHONE:		215 702-8550

	MAIL ADDRESS:	
		STREET 1:		2150 CABOT BLVD WEST,
		STREET 2:		SUITE B
		CITY:			LANGHORNE
		STATE:			PA
		ZIP:			19047

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AquaMed Technologies, Inc.
		DATE OF NAME CHANGE:	20090723
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0609</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2026-07-23</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001468929</issuerCik>
        <issuerName>NEXGEL, INC.</issuerName>
        <issuerTradingSymbol>NXGL</issuerTradingSymbol>
        <issuerForeignTradingSymbol></issuerForeignTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001794090</rptOwnerCik>
            <rptOwnerName>Levy Adam R.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerNonUSAddressFlag>false</rptOwnerNonUSAddressFlag>
            <rptOwnerStreet1>C/O NEXGEL, INC. 2150 CABOT BLVD, WEST,</rptOwnerStreet1>
            <rptOwnerStreet2>SUITE B</rptOwnerStreet2>
            <rptOwnerCity>LANGHORNE</rptOwnerCity>
            <rptOwnerState>PA</rptOwnerState>
            <rptOwnerZipCode>19047</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Chief Executive Officer</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <aff10b5One>0</aff10b5One>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Stock Option (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>0.647</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2026-07-23</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness></transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>160000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2031-07-23</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>160000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>160000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">The option becomes exercisable as to 40,000 shares on December 31, 2026, and as to the remaining 120,000 shares in 36 equal monthly installments of 3,334 shares (with rounding adjustments) beginning January 31, 2027, in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. In the event of a Change in Control (as defined in the Reporting Person's Executive Employment Agreement with the Issuer, dated July 23, 2026), any unvested portion of the option will accelerate and become immediately exercisable in full.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Adam Levy</signatureName>
        <signatureDate>2026-07-29</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
